<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
WASHINGTON, D.C. 20549<BR>
<BR>
<FONT STYLE="text-transform: none">Form </FONT>8-K<BR>
<BR>
current report<BR>
P<FONT STYLE="text-transform: none">ursuant to Section 13 or 15(d) of the</FONT><BR>
<FONT STYLE="text-transform: none">Securities Exchange Act of 1934</FONT><BR>
<BR>
<FONT STYLE="font-weight: normal">D<FONT STYLE="text-transform: none">ate of Report (Date of earliest event reported) </FONT></FONT>November
1, 2012</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none">NEWBRIDGE
BANCORP</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-weight: normal; text-transform: none">(Exact
Name of Registrant as Specified in Charter)</FONT><BR>
<BR>
</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center">North Carolina</TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center">000-11448</TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center">56-1348147</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">State or Other Jurisdiction</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(Commission File Number)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(IRS Employer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 0.25in; padding-left: 5.4pt; text-align: center">of Incorporation)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 0.25in; padding-left: 5.4pt; text-align: center"></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 0.25in; padding-left: 5.4pt; text-align: center">Identification No.)</TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-weight: bold; text-decoration: none">1501 Highwoods Boulevard, Suite 400, Greensboro North Carolina</TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-weight: bold; text-decoration: none">27410</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-weight: normal; text-decoration: none">(Address of Principal Executive Offices)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-weight: normal; text-decoration: none">(Zip Code)</TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><BR>
<BR>
<FONT STYLE="font-weight: normal">Registrant&rsquo;s telephone number, including area code</FONT> (336) 369-0900</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&#9;Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><FONT STYLE="font-family: Wingdings">&#120;</FONT>&#9;Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&#9;Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&#9;Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">INDEX</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-decoration: underline; text-align: right">Page</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 90%; padding-right: 5.4pt; padding-left: 5.4pt">Item 1.01 - Entry into Material Definitive Agreement</TD>
    <TD STYLE="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">3</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item 2.02 &ndash; Results of Operations and Financial Condition&#9;</P>
</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">5</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Item 3.02 - Unregistered Sales of Equity Securities</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">5</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Item 9.01 &ndash; Financial Statements and Exhibits6</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">6</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Signatures</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">7</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 1.01. Entry into Material Definitive Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On November 1, 2012, NewBridge Bancorp (the &ldquo;<U>Company</U>&rdquo;)
entered into securities purchase agreements (the &ldquo;<U>Purchase Agreements</U>&rdquo;) with 22 separate purchasers, including
certain officers and directors of the Company (each an &ldquo;Investor,&rdquo; and collectively, the &ldquo;<U>Investors</U>&rdquo;),
pursuant to which the Investors will invest an aggregate of $56 million in cash in the Company through direct purchases of newly
issued Series B Mandatorily Convertible Adjustable Rate Cumulative Perpetual Preferred Stock (the &ldquo;<U>Series B Preferred
Stock</U>&rdquo;) and Series C Mandatorily Convertible Adjustable Rate Cumulative Perpetual Preferred Stock (the &ldquo;<U>Series
C Preferred Stock</U>&rdquo;). The investments in the Series B Preferred Stock and the Series C Preferred Stock shall collectively
be referred to herein as the &ldquo;<U>Investments</U>&rdquo; or the &ldquo;<U>Preferred Stock</U>&rdquo;. A press release announcing
the signing of the Purchase Agreements and the other matters disclosed herein is attached to this filing as Exhibit&nbsp;99.1 and
incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company presently expects the sale of the Preferred Stock,
which is subject to certain customary closing conditions, including the receipt of customary regulatory approvals and determinations,
to close during the fourth quarter, 2012 (the &ldquo;<U>Closing</U>&rdquo;). At Closing, the Company will issue an aggregate of
424,435 shares of Series B Preferred Stock and 140,217 shares of Series C Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Each of the Series B Preferred Stock and the Series C Preferred
Stock is a new series of the Company&rsquo;s preferred stock, and is non-voting other than customary limited voting rights with
respect to matters significantly and adversely affecting the rights and privileges of the applicable series of Preferred Stock.
With respect to dividend rights and rights on liquidation, winding up and dissolution, both series of the Preferred Stock will
rank (i) on parity with the Company&rsquo;s Fixed Rate Cumulative Perpetual Preferred Stock, Series A (the &ldquo;Series A Preferred
Stock&rdquo;) and (ii) senior to the Company&rsquo;s common stock, par value $5.00 per share (the &ldquo;Common Stock&rdquo;).
Each series of the Preferred Stock has a liquidation preference of $100 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Each share of the Preferred Stock will receive cumulative dividends
as follows: (i) five percent (5%) for a period of six months following issuance, (ii) six percent (6%) for the next six months,
(iii) seven percent (7%) for the next six months, and (iii) eight percent (8%) thereafter. If the Preferred Stock is converted
to Common Stock (as described below) within the first six month period, no dividends will be owed or paid on the Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preferences, limitations, and relative rights of the Series
B Preferred Stock and the Series C Preferred Stock will be set forth in Articles of Amendment and Certificate of Designation that
will be filed prior to the Closing with the Secretary of State of the State of North Carolina (the &ldquo;Articles of Amendment&rdquo;).
The Articles of Amendment are attached to this filing as Exhibit&nbsp;3.1 and are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the Purchase Agreements, the Company will seek the
approval of its shareholders at a Special Meeting of Shareholders expected to be held in the first quarter of 2013 for (i) an amendment
to the Company&rsquo;s Articles of Incorporation (the &ldquo;<U>Common Stock Articles of Amendment</U>&rdquo;) to (a) increase
the number of authorized shares of the Company&rsquo;s common and preferred stock, and (b) establish two separate classes of common
stock, with all issued and outstanding shares of Common Stock becoming voting &ldquo;<U>Class A Common Stock</U>&rdquo;, and the
creation of a new class of non-voting common stock designated &ldquo;<U>Class B Common Stock&rdquo;</U>, and (ii) the issuance
of shares of Class A Common Stock in connection with the conversion of the Series B Preferred Stock, and shares of Class B Common
Stock in connection with the conversion of the Series C Preferred Stock, for purposes of NASDAQ Marketplace Rule 5635 (collectively,
the &ldquo;<U>Shareholder Approvals</U>&rdquo;). The Common Stock Articles of Amendment are attached to this filing as Exhibit&nbsp;3.2
and are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Following receipt of the Shareholder Approvals and the filing
of the Common Stock Articles of Amendment with the Secretary of State for the State of North Carolina, the Series B Preferred
Stock will automatically convert into Class A Common Stock, and the Series C Preferred Stock will automatically convert into Class
B Common Stock, in each case at a conversion price of $4.40 per share of common stock, subject to customary anti-dilution adjustments.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the Investments, subject to satisfaction
of all legal, regulatory, securities listing and governance requirements, one Investor will be entitled to nominate a director
(the &ldquo;<U>Designated Director</U>&rdquo;) to serve on the Board of Directors of the Company (the &ldquo;<U>Board</U>&rdquo;)
and the Board of Directors of the Bank (the &ldquo;<U>Bank Board</U>&rdquo;), and appoint an observer to attend meetings of the
Board and the Bank Board in a non-voting &ldquo;observer&rdquo; capacity. With respect to each annual meeting of shareholders following
the Closing, subject to satisfaction of all legal, regulatory, securities listing and governance requirements and for so long as
such Investor beneficially owns at least 4.9% of the Company&rsquo;s outstanding shares of Class A Common Stock on an as-converted
basis, the Designated Director shall be nominated by the Nominating Committee of the Board to serve on the Board and on the Bank
Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">No Investor will own more than 9.9% of the Company&rsquo;s voting
securities (or securities that convert into voting securities in the hands of such Investor) on an as-converted basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company intends to use the proceeds from the Investments
(a) for capital purposes of its wholly-owned subsidiary, NewBridge Bank (the &ldquo;Bank&rdquo;), to support the Bank&rsquo;s disposition
of selected classified and non-performing assets in accordance with the Bank&rsquo;s asset disposition plan, (b) to repurchase
the preferred stock and the warrant issued to the U.S. Treasury through the Troubled Asset Relief Program, and (c) to support the
operations of the Company and the Bank.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the Purchase Agreements, the Company and the Investors
also entered into Registration Rights Agreements, which provide the Investors with certain registration rights with respect to
the Preferred Stock and the shares of Class A Common Stock and Class B Common Stock into which the Preferred Stock converts (the
&ldquo;Underlying Shares&rdquo;). Among other things, the Registration Rights Agreements require the Company to file a resale registration
statement, or statements if necessary, with respect to the Preferred Stock and the Underlying Shares within 30 days following the
Company&rsquo;s receipt of the Shareholder Approvals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The foregoing description of the Articles of Amendment, the
Common Stock Articles of Amendment, the Purchase Agreements and the Registration Rights Agreements is a summary and does not purport
to be a complete description of all of the terms of such documents and is qualified in its entirety by reference to such documents,
which are attached hereto as Exhibits 3.1, 3.2, 10.1 and 10.2, respectively. The Purchase Agreements and the Registration Rights
Agreement include representations and warranties each party has made to the other. The assertions embodied in the representations
and warranties are qualified by information in confidential disclosure schedules the parties delivered to each other when they
executed the Purchase Agreements and the Registration Rights Agreements. Certain representations and warranties were made as of
a specific date, may be subject to a contractual standard of materiality different from those generally applicable to shareholders
and investors, or may have been used for purposes of allocating risk between the respective parties rather than establishing matters
as facts. Accordingly, investors should not rely on the representations and warranties as characterizations of the actual state
of facts at the time they were made or otherwise, and investors should not rely on the representations and warranties for any other
purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item&nbsp;2.02. Results of Operations and Financial Condition</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On November 1, 2012, the Company issued a press release announcing
earnings for the three and nine months ended September 30, 2012. A copy of the press release is attached to this filing as Exhibit&nbsp;99.1
and incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 3.02. Unregistered Sales of Equity Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information set forth in Item 1.01 hereof concerning the
Investments is incorporated herein by reference. The shares of Preferred Stock to be issued and sold in the transactions described
in Item 1.01 were offered and will be sold by the Company in reliance upon an exemption from registration pursuant to Rule 4(2)
of the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">FIG Partners, LLC and  Keefe, Bruyette &amp; Woods, Inc. served
as Placement Agents with respect to the Investments, and will receive compensation of $2,612,500 in the aggregate due upon the
Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Additional Information</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with certain matters related to the Investments,
the Company intends to file with the Securities and Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;) a proxy statement with respect
to the Shareholder Approvals. The Company will mail the definitive proxy statement, when available, to its shareholders. Investors
and security holders are urged to read the proxy statement with regards to certain matters related to the transaction described
in Item 1.01 when it becomes available because it will contain important information. You may obtain a free copy of the proxy statement
(when available) and other related documents filed by the Company with the SEC at the SEC&rsquo;s website at <I>www.sec.gov</I>
or from the Company&rsquo;s website at <I>www.newbridgebank.com</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company and its directors, executive officers and certain
other members of management and employees may be soliciting proxies from shareholders in favor of certain matters relating to the
transactions described in Item 1.01. Investors may obtain additional information regarding the interest of Company&rsquo;s executive
officers and directors in the contemplated transaction by reading the proxy statement regarding the matters related to the transactions
described in Item 1.01 when it becomes available.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Disclosures About Forward Looking Statements
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The discussions included in this document
and its exhibits may contain forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995,
including Section 21E of the Securities Exchange Act of 1934 and Section 27A of the Securities Act of 1933. Such statements involve
known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. For the purposes of
these discussions, any statements that are not statements of historical fact may be deemed to be forward looking statements. Such
statements are often characterized by the use of qualifying words such as &ldquo;expects,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo;
&ldquo;estimates,&rdquo; &ldquo;plans,&rdquo; &ldquo;projects,&rdquo; or other statements concerning opinions or judgments of the
Company and its management about future events. The accuracy of such forward looking statements could be affected by factors including,
but not limited to, successful completion of the capital raise described above, receipt of customary regulatory approvals and determinations
referenced above, receipt of the shareholder approval referenced above, the financial success or changing conditions or strategies
of the Company&rsquo;s clients or vendors, fluctuations in interest rates, actions of government regulators, the availability of
capital and personnel or general economic conditions. Additional factors that could cause actual results to differ materially from
those anticipated by forward looking statements are discussed in the Company&rsquo;s filings with the Securities and Exchange Commission,
including without limitation its annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. The
Company undertakes no obligation to revise or update these statements following the date of this filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item&nbsp;9.01. Financial Statements and Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-decoration: underline">Exhibit No.</TD>
    <TD STYLE="width: 90%; padding-right: 5.4pt; padding-left: 5.4pt; text-decoration: underline">Description of Exhibit</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">3.1</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Form of Articles of Amendment to Designate the Terms of the Series B Mandatorily Convertible Adjustable Rate Cumulative Perpetual Preferred Stock and Series C Mandatorily Convertible Adjustable Rate Cumulative Perpetual Preferred Stock.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">3.2</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Form of Common Stock Articles of Amendment</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">10.1</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Securities Purchase Agreement</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">10.2</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Registration Rights Agreement</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">99.1</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Press release of NewBridge Bancorp dated November 1, 2012.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: November 1, 2012</P></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NEWBRIDGE BANCORP</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By:<U>&#9;/s/ Ramsey K. Hamadi&#9;</U></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30.6pt">Ramsey K. Hamadi,</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30.6pt">Chief Financial Officer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-decoration: underline">Exhibit No.</TD>
    <TD STYLE="width: 90%; padding-right: 5.4pt; padding-left: 5.4pt; text-decoration: underline">Description of Exhibit</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">3.1</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Form of Articles of Amendment to Designate the Terms of the Series B Mandatorily Convertible Adjustable Rate Cumulative Perpetual Preferred Stock and Series C Mandatorily Convertible Adjustable Rate Cumulative Perpetual Preferred Stock.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">3.2</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Form of Common Stock Articles of Amendment</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">10.1</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Securities Purchase Agreement</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">10.2</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Registration Rights Agreement</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">99.1</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Press release of NewBridge Bancorp dated November 1, 2012.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v326943_8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 38419}]
{"company-data": {"conformed-name": "NEWBRIDGE BANCORP", "cik": "0000714530", "assigned-sic": "6022", "irs-number": "561348147", "state-of-incorporation": "NC", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-11448", "film-number": "121173013"}, "business-address": {"street1": "P O BOX 867", "street2": "ONE LSB PLZ", "city": "LEXINGTON", "state": "NC", "zip": "27293-0867", "phone": "3362486500"}, "mail-address": {"street1": "P O BOX 867", "city": "LEXINGTON", "state": "NC", "zip": "27293-0867"}, "former-company": {"former-conformed-name": "LSB BANCSHARES INC /NC/", "date-changed": "19920703"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form
8-K
current report
P
ursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
D
ate of Report (Date of earliest event reported)
November
1, 2012
NEWBRIDGE
BANCORP
(Exact
Name of Registrant as Specified in Charter)
North Carolina
000-11448
56-1348147
State or Other Jurisdiction
(Commission File Number)
(IRS Employer
of Incorporation)
Identification No.)
1501 Highwoods Boulevard, Suite 400, Greensboro North Carolina
27410
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number, including area code
(336) 369-0900
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
x
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
INDEX
Page
Item 1.01 - Entry into Material Definitive Agreement
3
Item 2.02 – Results of Operations and Financial Condition
5
Item 3.02 - Unregistered Sales of Equity Securities
5
Item 9.01 – Financial Statements and Exhibits6
6
Signatures
7
2
Item 1.01. Entry into Material Definitive Agreement
On November 1, 2012, NewBridge Bancorp (the "
Company
")
entered into securities purchase agreements (the "
Purchase Agreements
") with 22 separate purchasers, including
certain officers and directors of the Company (each an "Investor," and collectively, the "
Investors
"),
pursuant to which the Investors will invest an aggregate of $56 million in cash in the Company through direct purchases of newly
issued Series B Mandatorily Convertible Adjustable Rate Cumulative Perpetual Preferred Stock (the "
Series B Preferred
Stock
") and Series C Mandatorily Convertible Adjustable Rate Cumulative Perpetual Preferred Stock (the "
Series
C Preferred Stock
"). The investments in the Series B Preferred Stock and the Series C Preferred Stock shall collectively
be referred to herein as the "
Investments
" or the "
Preferred Stock
". A press release announcing
the signing of the Purchase Agreements and the other matters disclosed herein is attached to this filing as Exhibit 99.1 and
incorporated herein by reference.
The Company presently expects the sale of the Preferred Stock,
which is subject to certain customary closing conditions, including the receipt of customary regulatory approvals and determinations,
to close during the fourth quarter, 2012 (the "
Closing
"). At Closing, the Company will issue an aggregate of
424,435 shares of Series B Preferred Stock and 140,217 shares of Series C Preferred Stock.
Each of the Series B Preferred Stock and the Series C Preferred
Stock is a new series of the Company's preferred stock, and is non-voting other than customary limited voting rights with
respect to matters significantly and adversely affecting the rights and privileges of the applicable series of Preferred Stock.
With respect to dividend rights and rights on liquidation, winding up and dissolution, both series of the Preferred Stock will
rank (i) on parity with the Company's Fixed Rate Cumulative Perpetual Preferred Stock, Series A (the "Series A Preferred
Stock") and (ii) senior to the Company's common stock, par value $5.00 per share (the "Common Stock").
Each series of the Preferred Stock has a liquidation preference of $100 per share.
Each share of the Preferred Stock will receive cumulative dividends
as follows: (i) five percent (5%) for a period of six months following issuance, (ii) six percent (6%) for the next six months,
(iii) seven percent (7%) for the next six months, and (iii) eight percent (8%) thereafter. If the Preferred Stock is converted
to Common Stock (as described below) within the first six month period, no dividends will be owed or paid on the Preferred Stock.
The preferences, limitations, and relative rights of the Series
B Preferred Stock and the Series C Preferred Stock will be set forth in Articles of Amendment and Certificate of Designation that
will be filed prior to the Closing with the Secretary of State of the State of North Carolina (the "Articles of Amendment").
The Articles of Amendment are attached to this filing as Exhibit 3.1 and are incorporated herein by reference.
Pursuant to the Purchase Agreements, the Company will seek the
approval of its shareholders at a Special Meeting of Shareholders expected to be held in the first quarter of 2013 for (i) an amendment
to the Company's Articles of Incorporation (the "
Common Stock Articles of Amendment
") to (a) increase
the number of authorized shares of the Company's common and preferred stock, and (b) establish two separate classes of common
stock, with all issued and outstanding shares of Common Stock becoming voting "
Class A Common Stock
", and the
creation of a new class of non-voting common stock designated "
Class B Common Stock"
, and (ii) the issuance
of shares of Class A Common Stock in connection with the conversion of the Series B Preferred Stock, and shares of Class B Common
Stock in connection with the conversion of the Series C Preferred Stock, for purposes of NASDAQ Marketplace Rule 5635 (collectively,
the "
Shareholder Approvals
"). The Common Stock Articles of Amendment are attached to this filing as Exhibit 3.2
and are incorporated herein by reference.
3
Following receipt of the Shareholder Approvals and the filing
of the Common Stock Articles of Amendment with the Secretary of State for the State of North Carolina, the Series B Preferred
Stock will automatically convert into Class A Common Stock, and the Series C Preferred Stock will automatically convert into Class
B Common Stock, in each case at a conversion price of $4.40 per share of common stock, subject to customary anti-dilution adjustments.
In connection with the Investments, subject to satisfaction
of all legal, regulatory, securities listing and governance requirements, one Investor will be entitled to nominate a director
(the "
Designated Director
") to serve on the Board of Directors of the Company (the "
Board
")
and the Board of Directors of the Bank (the "
Bank Board
"), and appoint an observer to attend meetings of the
Board and the Bank Board in a non-voting "observer" capacity. With respect to each annual meeting of shareholders following
the Closing, subject to satisfaction of all legal, regulatory, securities listing and governance requirements and for so long as
such Investor beneficially owns at least 4.9% of the Company's outstanding shares of Class A Common Stock on an as-converted
basis, the Designated Director shall be nominated by the Nominating Committee of the Board to serve on the Board and on the Bank
Board.
No Investor will own more than 9.9% of the Company's voting
securities (or securities that convert into voting securities in the hands of such Investor) on an as-converted basis.
The Company intends to use the proceeds from the Investments
(a) for capital purposes of its wholly-owned subsidiary, NewBridge Bank (the "Bank"), to support the Bank's disposition
of selected classified and non-performing assets in accordance with the Bank's asset disposition plan, (b) to repurchase
the preferred stock and the warrant issued to the U.S. Treasury through the Troubled Asset Relief Program, and (c) to support the
operations of the Company and the Bank.
Pursuant to the Purchase Agreements, the Company and the Investors
also entered into Registration Rights Agreements, which provide the Investors with certain registration rights with respect to
the Preferred Stock and the shares of Class A Common Stock and Class B Common Stock into which the Preferred Stock converts (the
"Underlying Shares"). Among other things, the Registration Rights Agreements require the Company to file a resale registration
statement, or statements if necessary, with respect to the Preferred Stock and the Underlying Shares within 30 days following the
Company's receipt of the Shareholder Approvals.
4
The foregoing description of the Articles of Amendment, the
Common Stock Articles of Amendment, the Purchase Agreements and the Registration Rights Agreements is a summary and does not purport
to be a complete description of all of the terms of such documents and is qualified in its entirety by reference to such documents,
which are attached hereto as Exhibits 3.1, 3.2, 10.1 and 10.2, respectively. The Purchase Agreements and the Registration Rights
Agreement include representations and warranties each party has made to the other. The assertions embodied in the representations
and warranties are qualified by information in confidential disclosure schedules the parties delivered to each other when they
executed the Purchase Agreements and the Registration Rights Agreements. Certain representations and warranties were made as of
a specific date, may be subject to a contractual standard of materiality different from those generally applicable to shareholders
and investors, or may have been used for purposes of allocating risk between the respective parties rather than establishing matters
as facts. Accordingly, investors should not rely on the representations and warranties as characterizations of the actual state
of facts at the time they were made or otherwise, and investors should not rely on the representations and warranties for any other
purpose.
Item 2.02. Results of Operations and Financial Condition
On November 1, 2012, the Company issued a press release announcing
earnings for the three and nine months ended September 30, 2012. A copy of the press release is attached to this filing as Exhibit 99.1
and incorporated herein by reference.
Item 3.02. Unregistered Sales of Equity Securities
The information set forth in Item 1.01 hereof concerning the
Investments is incorporated herein by reference. The shares of Preferred Stock to be issued and sold in the transactions described
in Item 1.01 were offered and will be sold by the Company in reliance upon an exemption from registration pursuant to Rule 4(2)
of the Securities Act of 1933, as amended.
FIG Partners, LLC and  Keefe, Bruyette & Woods, Inc. served
as Placement Agents with respect to the Investments, and will receive compensation of $2,612,500 in the aggregate due upon the
Closing.
Additional Information
In connection with certain matters related to the Investments,
the Company intends to file with the Securities and Exchange Commission (the "
SEC
") a proxy statement with respect
to the Shareholder Approvals. The Company will mail the definitive proxy statement, when available, to its shareholders. Investors
and security holders are urged to read the proxy statement with regards to certain matters related to the transaction described
in Item 1.01 when it becomes available because it will contain important information. You may obtain a free copy of the proxy statement
(when available) and other related documents filed by the Company with the SEC at the SEC's website at
www.sec.gov
or from the Company's website at
www.newbridgebank.com
.
The Company and its directors, executive officers and certain
other members of management and employees may be soliciting proxies from shareholders in favor of certain matters relating to the
transactions described in Item 1.01. Investors may obtain additional information regarding the interest of Company's executive
officers and directors in the contemplated transaction by reading the proxy statement regarding the matters related to the transactions
described in Item 1.01 when it becomes available.
5
Disclosures About Forward Looking Statements
The discussions included in this document
and its exhibits may contain forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995,
including Section 21E of the Securities Exchange Act of 1934 and Section 27A of the Securities Act of 1933. Such statements involve
known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. For the purposes of
these discussions, any statements that are not statements of historical fact may be deemed to be forward looking statements. Such
statements are often characterized by the use of qualifying words such as "expects," "anticipates," "believes,"
"estimates," "plans," "projects," or other statements concerning opinions or judgments of the
Company and its management about future events. The accuracy of such forward looking statements could be affected by factors including,
but not limited to, successful completion of the capital raise described above, receipt of customary regulatory approvals and determinations
referenced above, receipt of the shareholder approval referenced above, the financial success or changing conditions or strategies
of the Company's clients or vendors, fluctuations in interest rates, actions of government regulators, the availability of
capital and personnel or general economic conditions. Additional factors that could cause actual results to differ materially from
those anticipated by forward looking statements are discussed in the Company's filings with the Securities and Exchange Commission,
including without limitation its annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. The
Company undertakes no obligation to revise or update these statements following the date of this filing.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
Exhibit No.
Description of Exhibit
3.1
Form of Articles of Amendment to Designate the Terms of the Series B Mandatorily Convertible Adjustable Rate Cumulative Perpetual Preferred Stock and Series C Mandatorily Convertible Adjustable Rate Cumulative Perpetual Preferred Stock.
3.2
Form of Common Stock Articles of Amendment
10.1
Securities Purchase Agreement
10.2
Registration Rights Agreement
99.1
Press release of NewBridge Bancorp dated November 1, 2012.
6
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
Dated: November 1, 2012
NEWBRIDGE BANCORP
By:
/s/ Ramsey K. Hamadi
Ramsey K. Hamadi,
Chief Financial Officer
7
EXHIBIT INDEX
Exhibit No.
Description of Exhibit
3.1
Form of Articles of Amendment to Designate the Terms of the Series B Mandatorily Convertible Adjustable Rate Cumulative Perpetual Preferred Stock and Series C Mandatorily Convertible Adjustable Rate Cumulative Perpetual Preferred Stock.
3.2
Form of Common Stock Articles of Amendment
10.1
Securities Purchase Agreement
10.2
Registration Rights Agreement
99.1
Press release of NewBridge Bancorp dated November 1, 2012.
8